<DOC>
	<DOCNO>NCT01872832</DOCNO>
	<brief_summary>This study explore safety , tolerability , serum uric acid lower effect RDEA3170 healthy Japanese male allow comparison Western population .</brief_summary>
	<brief_title>Single Multiple Dose Study Japanese Subjects</brief_title>
	<detailed_description>While clinical study RDEA3170 date limit Western population , recognize intrinsic extrinsic factor may impact PK , PD , safety , dose response different ethnic population . The purpose study explore safety , tolerability , pharmacokinetic ( PK ) , pharmacodynamic ( PD ) single multiple dos RDEA3170 healthy Japanese male , allow comparison parameter Western population .</detailed_description>
	<criteria>Able understand study procedures risk involve , willing provide write informed consent first study related activity . Healthy adult male subject bear Japan . Subject parent grandparent Japanese . Subject possession valid Japanese passport . All laboratory parameter within normal limit consider clinically significant investigator . Screening serum urate level â‰¥ 4.5 mg/dL . Subject free clinically significant disease require physician 's care and/or would interfere study evaluation procedure . Subject normal clinically acceptable physical examination . Subject clinically relevant abnormality blood pressure , heart rate , body temperature , per Investigator 's judgment . Positive serology human immunodeficiency virus ( HIV1 HIV2 ) . Positive test active hepatitis B hepatitis C infection . History suspicion kidney stone . Undergone major surgery within 3 month prior Day 1 . Exposed investigational drug ( medical device ) within 30 day 5 halflives investigational drug ( whichever longer ) prior Day 1 currently participate another study investigational drug ( medical device ) . Prior exposure RDEA3170 .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>